Global Tumor Ablation Market – Industry Trends and Forecast to 2024

  • Medical Devices
  • Publish Reports
  • Nov 2017
  • Global
  • 188 Pages
  • No of Tables: 54
  • No of Figures: 48
Global Tumor Ablation market By Type (Tumor Ablation Systems {Radio Frequency Ablation System, Microwave Ablation System, Cryoablation, High Intensity Focused Ultrasound , Laser Ablation System}, Image Guidance Products, Accessories), By Cancer Type (Liver Cancer, Brain Cancer, Lung Cancer, Bone Cancer, Kidney Cancer, Pancreatic Cancer, Breast Cancer, Others), By Mode of Treatment (Surgical, Laparoscopic, Percutaneous), By End User (Hospitals, Oncology Clinics, Others), By Region (North America, Europe, Asia Pacific, South America, Middle East and Africa)– Industry Trends and Forecast to 2024 Global Tumor Ablation Market is expected to reach USD 3,495.0 million by 2024 from USD 1,669.7 million in 2016, at a CAGR of 9.8% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.Global Tumor Ablation MarketThe major factors contributing to the growth of the market includes incidences of cancer patients, increase in the number of hospitals, ablation and surgical centers, technological advancement in ablation devices. On the other hand, stringent regulatory process would restrain the growth of the market.

Market Segmentation: Global Tumor Ablation Market

  • The global tumor ablation market is segmented on the basis of type, cancer type, mode of treatment, end user, and geography. On the basis of type, the market is segmented into three major segments which include tumor ablation systems, image guidance products, and accessories. In 2017, the Tumor Ablation Systems market segment is expected to dominate the market with 69.2%. Tumor Ablation Systems is further sub segmented into radio frequency ablation system (RFA), microwave ablation system, cryoablation, high intensity focused ultrasound and laser ablation system. In 2017, radio frequency ablation system (RFA) market segment is expected to dominate the market with 53.8%.
  • On the basis of cancer type, the market is segmented into eight major segments which include liver cancer, brain cancer, lung cancer, bone cancer, kidney cancer, pancreatic cancer, breast cancer and others, The lung cancer market is expected to grow at the highest CAGR 10.7% in the forecast period of 2017 to 2024.
  • Based on mode of treatment, the global tumor ablation market is segmented into surgical, laproscopic and percutaneous. The Surgical is projected to witness higher growth during the forecast period., The laparoscopic market is expected to grow at the highest CAGR 10.8% in the forecast period of 2017 to 2024.
  • On the basis of end users, the market is segmented into hospital, oncology clinics, and others. In 2017, the hospital market segment is expected to dominate the market. with a share of 68.3%.
  • Based on geography, the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa.

Key Drivers: Global Tumor Ablation Market

Some of the major factors driving the market for global tumor ablation market are increasing incidences of cancer patients, increase in the number of hospitals, ablation and surgical centers, technological advancement in ablation devices. These factors increase the demand for devices such as tumor ablation systems and image guidance products.

  • High treatment cost and side effects associated with ablation treatment may hinder the growth of this market.
  • According to American Cancer Society, in 2017, approximately 1,688,780 new cancer cases were diagnosed and 600,920 cancer deaths were reported in the US.
  • Many companies are increasingly focusing on technological advancement of devices in order to strengthen their product portfolios in the tumor ablation market.

Key Points: Global Tumor Ablation Market

Medtronic is going to dominate the global tumor ablation market following with, Boston Scientific Corporation and Abbott along with others such as Galil Medical Inc., Perseon Corporation, NeuWave Medical, Inc., Koninklijke Philips N.V., INTIO Inc., Mermaid Medical A/S, SonaCare Medical, LLC, DFINE, Inc., Misonix, BVM Medical Limited, AngioDynamics, COMSOL Inc, EDAP TMS, and HealthTronics, Inc.

  • In 2017, the tumor ablation systems segment is expected to account for the largest share of 69.2% of the global tumor ablation market, by type. This segment is expected to grow at the highest CAGR of 10.2% in the forecast period 2017 to 2024.
  • Radio frequency ablation system segment is going to dominate the tumor ablation market owing to effective treatment for small cancers, minimal risk to patient, and faster results will drive the growth of the market.

SKU-

TABLE OF CONTENTS GLOBAL TUMOR ABLATION MARKET

1. INTRODUCTION

1.1. OBJECTIVES OF THE STUDY 1.2. MARKET DEFINITION 1.3. MARKET SCOPE 1.4. OVERVIEW OF GLOBAL TUMOR ABLATION MARKET 1.5. CURRENCY AND PRICING 1.6. LIMITATION 1.7. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED 2.2. GEOGRAPHIC SCOPE 2.3. YEARS CONSIDERED FOR THE STUDY 2.4. CURRENCY AND PRICING 2.5. RESEARCH METHODOLOGY 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7. SECONDARY SOURCE 2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. INCREASING PREVALENCE OF CANCER PATIENTS 3.1.2. TECHNOLOGICAL ADVANCEMENTS IN ABLATION DEVICES 3.1.3. RISING NUMBER OF HOSPITALS, SURGICAL, AND ABLATION CENTERS

3.2. RESTRAINTS

3.2.1. HIGH COST OF TUMOR ABLATION TREATMENT 3.2.2. SIDE EFFECTS ASSOCIATED WITH ABLATION TREATMENT 3.2.3. SHORTAGE OF SKILLED AND TRAINED PROFESSIONALS

3.3. OPPORTUNITIES

3.3.1. GROWTH POTENTIAL OFFERED BY DEVELOPING MARKETS 3.3.2. GROWING AWARENESS ABOUT ABLATION PROCEDURES

3.4. CHALLENGES

3.4.1. STRINGENT REGULATORY GUIDELINES

4. EXECUTIVE SUMMARY 5. PREMIUM INSIGHTS 6. GLOBAL TUMOR ABLATION MARKET, BY TYPE

6.1. OVERVIEW

6.2. TUMOR ABLATION SYSTEMS

6.2.1. RADIOFREQUENCY ABLATION SYSTEM (RFA) 6.2.2. MICROWAVE ABLATION SYSTEM 6.2.3. HIGH FREQUENCY FOCUSED ULTRASOUND ABLATION SYSTEM (HIFU) 6.2.4. LASER ABLATION SYSTEM 6.2.5. CRYOABLATION

6.3. IMAGE GUIDANCE PRODUCTS

6.4. ACCESSORIES

7. GLOBAL TUMOR ABLATION MARKET, BY CANCER TYPE

7.1. OVERVIEW 7.2. LIVER CANCER 7.3. BRAIN CANCER 7.4. LUNG CANCER 7.5. BONE CANCER 7.6. KIDNEY CANCER 7.7. PANCREATIC CANCER 7.8. BREAST CANCER 7.9. OTHERS

8. GLOBAL TUMOR ABLATION MARKET, BY MODE OF TREATMENT

8.1. OVERVIEW 8.2. SURGICAL 8.3. LAPAROSCOPIC 8.4. PERCUTANEOUS

9. GLOBAL TUMOR ABLATION MARKET, BY END USER

9.1. OVERVIEW 9.2. HOSPITALS 9.3. ONCOLOGY CLINICS 9.4. OTHERS

10. GLOBAL TUMOR ABLATION MARKET, BY GEOGRAPHY

10.1. OVERVIEW 10.2. NORTH AMERICA 10.3. EUROPE 10.4. ASIA-PACIFIC 10.5. SOUTH AMERICA 10.6. MIDDLE EAST AND AFRICA

11. GLOBAL TUMOR ABLATION MARKET, COMPANY LANDSCAPE

11.1. COMPANY SHARE ANALYSIS: GLOBAL 11.2. COMPANY SHARE ANALYSIS: NORTH AMERICA 11.3. COMPANY SHARE ANALYSIS: EUROPE 11.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC

12. COMPANY PROFILES

1.1. MEDTRONIC

1.1.1. COMPANY OVERVIEW 1.1.2. MEDTRONIC :REVENUE ANALYSIS 1.1.3. PRODUCT PORTFOLIO 1.1.4. RECENT DEVELOPMENTS

1.2. STRYKER

1.2.1. COMPANY OVERVIEW 1.2.2. STRYKER :REVENUE ANALYSIS 1.2.3. PRODUCT PORTFOLIO 1.2.4. RECENT DEVELOPMENTS

1.3. TERUMO CORPORATION

1.3.1. COMPANY OVERVIEW 1.3.2. TERUMO CORPORATION :REVENUE ANALYSIS 1.3.3. PRODUCT PORTFOLIO 1.3.4. RECENT DEVELOPMENTS

1.4. INTEGRA LIFESCIENCES CORPORATION

1.4.1. COMPANY OVERVIEW 1.4.2. INTEGRA LIFESCIENCES CORPORATION : REVENUE ANALYSIS 1.4.3. PRODUCT PORTFOLIO 1.4.4. RECENT DEVELOPMENTS

1.5. KONINKLIJKE PHILIPS N.V.

1.5.1. COMPANY OVERVIEW 1.5.2. KONINKLIJKE PHILIPS N.V.: REVENUE ANALYSIS 1.5.3. PRODUCT PORTFOLIO 1.5.4. RECENT DEVELOPMENTS

1.6. NEUWAVE MEDICAL, INC (ACQUIRED BY ETHICON US, LLC, SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)

1.6.1. COMPANY OVERVIEW 1.6.2. JOHNSON & JOHNSON SERVICES, INC.:REVENUE ANALYSIS 1.6.3. PRODUCT PORTFOLIO 1.6.4. RECENT DEVELOPMENTS

1.7. BOSTON SCIENTIFIC CORPORATION

1.7.1. COMPANY OVERVIEW 1.7.2. BOSTON SCIENTIFIC CORPORATION :REVENUE ANALYSIS 1.7.3. PRODUCT PORTFOLIO 1.7.4. RECENT DEVELOPMENTS

1.8. MERMAID MEDICAL A/S

1.8.1. COMPANY OVERVIEW 1.8.2. MERMAID MEDICAL A/S: COMPANY SNAPSHOT 1.8.3. PRODUCT PORTFOLIO 1.8.4. RECENT DEVELOPMENTS

1.9. SONACARE MEDICAL, LLC

1.9.1. COMPANY OVERVIEW 1.9.2. SONACARE MEDICAL, LLC.: COMPANY SNAPSHOT 1.9.3. PRODUCT PORTFOLIO 1.9.4. RECENT DEVELOPMENTS

1.10. MERIT MEDICAL SYSTEMS, INC

1.10.1. COMPANY OVERVIEW 1.10.2. MERIT MEDICAL SYSTEMS, INC.:REVENUE ANALYSIS 1.10.3. PRODUCT PORTFOLIO 1.10.4. RECENT DEVELOPMENTS

1.11. BVM MEDICAL LIMITED

1.11.1. COMPANY OVERVIEW 1.11.2. BVM MEDICAL LIMITED : COMPANY SNAPSHOT 1.11.3. PRODUCT PORTFOLIO 1.11.4. RECENT DEVELOPMENTS

1.12. INSIGHTEC LTD

1.12.1. COMPANY OVERVIEW 1.12.2. INSIGHTEC LTD :COMPANY SNAPSHOT 1.12.3. PRODUCT PORTFOLIO 1.12.4. RECENT DEVELOPMENTS

1.13. ABBOTT

1.13.1. COMPANY OVERVIEW 1.13.2. ABBOTT:REVENUE ANALYSIS 1.13.3. PRODUCT PORTFOLIO 1.13.4. RECENT DEVELOPMENTS

1.14. VYTRONUS, INC

1.14.1. COMPANY OVERVIEW 1.14.2. VYTRONUS, INC : COMPANY SNAPSHOT 1.14.3. PRODUCT PORTFOLIO 1.14.4. RECENT DEVELOPMENTS

1.15. BALYIS MEDICAL

1.15.1. COMPANY OVERVIEW 1.15.2. BAYLIS MEDICAL : COMPANY SNAPSHOT 1.15.3. PRODUCT PORTFOLIO 1.15.4. RECENT DEVELOPMENTS

1.16. EDAP TMS

1.16.1. COMPANY OVERVIEW 1.16.2. REVENUE ANALYSIS 1.16.3. PRODUCT PORTFOLIO 1.16.4. RECENT DEVELOPMENTS

1.17. ATRICURE, INC.

1.17.1. COMPANY OVERVIEW 1.17.2. REVENUE ANALYSIS 1.17.3. PRODUCT PORTFOLIO 1.17.4. RECENT DEVELOPMENTS

1.18. FCARE SYSTEMS

1.18.1. COMPANY OVERVIEW 1.18.2. FCARE SYSTEMS: COMPANY SNAPSHOT 1.18.3. PRODUCT PORTFOLIO 1.18.4. RECENT DEVELOPMENTS

1.19. ECO, INC.

1.19.1. COMPANY OVERVIEW 1.19.2. ECO INC. : COMPANY SNAPSHOT 1.19.3. PRODUCT PORTFOLIO 1.19.4. RECENT DEVELOPMENTS

1.20. NONINVASIVE MEDICAL DEVICES, LTD.

1.20.1. COMPANY OVERVIEW 1.20.2. NONINVASIVE MEDICAL DEVICES, LT. : COMPANY SNAPSHOT 1.20.3. PRODUCT PORTFOLIO 1.20.4. RECENT DEVELOPMENTS

13. RELATED REPORTS

LIST OF TABLE  GLOBAL TUMOR ABLATION MARKET

TABLE 1 GLOBAL TUMOR ABLATION MARKET, BY TYPE, 2015– 2024 (USD MILLION TABLE 2 GLOBAL TUMOR ABLATION SYSTEMS MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 3 GLOBAL TUMOR ABLATION SYSTEMS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 4 GLOBAL IMAGE GUIDANCE PRODUCT MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 5 GLOBAL ACCESSORIES MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 6 GLOBAL TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024(USD MILLION) TABLE 7 GLOBAL TUMOR ABLATION MARKET, LIVER CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 8 GLOBAL TUMOR ABLATION MARKET, BRAIN CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 9 GLOBAL TUMOR ABLATION MARKET, LUNG CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 10 GLOBAL TUMOR ABLATION MARKET, BONE CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 11 GLOBAL TUMOR ABLATION MARKET, KIDNEY CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 12 GLOBAL TUMOR ABLATION MARKET, PANCREATIC CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 13 GLOBAL TUMOR ABLATION MARKET, BREAST CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 14 GLOBAL TUMOR ABLATION MARKET,OTHERS, BY REGION, 2015 – 2024 (USD MILLION) TABLE 15 GLOBAL TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015– 2024 (USD MILLION) TABLE 16 GLOBAL SURGICAL TUMOR ABLATION MARKET, BY REGION, (2015-2024) USD MILLION TABLE 17 GLOBAL LAPAROSCOPIC TUMOR ABLATION MARKET, BY REGION, 2015-2024 (USD MILLION) TABLE 18 GLOBAL PERCUTANEOUS TUMOR ABLATION MARKET, BY REGION, 2015-2024 (USD MILLION) TABLE 19 GLOBAL TUMOR ABLATION MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 20 GLOBAL HOSPITALS TUMOR ABLATION MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 21 GLOBAL ONCOLOGY CLINICS TUMOR ABLATION MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 22 GLOBAL OTHERS TUMOR ABLATION MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 23 GLOBAL TUMOR ABLATION MARKET, BY GEOGRAPHY, 2015 – 2024 (USD MILLION) TABLE 24 NORTH AMERICA TUMOR ABLATION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 25 NORTH AMERICA TUMOR ABLATION MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 26 NORTH AMERICA TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024 (USD MILLION) TABLE 27 NORTH AMERICA TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015 – 2024 (USD MILLION) TABLE 28 NORTH AMERICA TUMOR ABLATION MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 29 EUROPE TUMOR ABLATION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 30 EUROPE TUMOR ABLATION MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 31 EUROPE TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024 (USD MILLION) TABLE 32 EUROPE TUMOR ABLATION MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 33 EUROPE TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015 – 2024 (USD MILLION) TABLE 34 ASIA-PACIFIC TUMOR ABLATION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 35 ASIA-PACIFIC TUMOR ABLATION MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 36 ASIA-PACIFIC TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024 (USD MILLION) TABLE 37 ASIA-PACIFIC TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015 – 2024 (USD MILLION) TABLE 38 ASIA-PACIFIC TUMOR ABLATION MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 39 SOUTH AMERICA TUMOR ABLATION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 40 SOUTH AMERICA TUMOR ABLATION MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 41 SOUTH AMERICA TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024 (USD MILLION) TABLE 42 SOUTH AMERICA TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015 – 2024 (USD MILLION) TABLE 43 SOUTH AMERICA TUMOR ABLATION MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 44 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 45 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 46 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024 (USD MILLION) TABLE 47 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015 – 2024 (USD MILLION) TABLE 48 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY END USER, 2015 – 2024 (USD MILLION)

LIST OF FIGURE GLOBAL TUMOR ABLATION MARKET

FIGURE 1 GLOBAL TUMOR ABLATION MARKET: SEGMENTATION FIGURE 2 GLOBAL TUMOR ABLATION MARKET: GEOGRAPHIC SCOPE FIGURE 3 GLOBAL TUMOR ABLATION MARKET: DATA TRIANGULATION FIGURE 4 GLOBAL TUMOR ABLATION MARKET : RESEARCH SNAPSHOT FIGURE 5 GLOBAL TUMOR ABLATION MARKET : BOTTOM UP APPROACH FIGURE 6 GLOBAL TUMOR ABLATION MARKET : TOP DOWN APPROACH FIGURE 7 GLOBAL TUMOR ABLATION MARKET: INTERVIEW DEMOGRAPHICS FIGURE 8 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF TUMOR ABLATION MARKET FIGURE 9 NUMBER OF DEATHS RECORDED GLOBALLY DUE TO VARIOUS TYPES OF CANCER, 2015 FIGURE 10 GLOBAL TUMOR ABLATION MARKET, BY TYPE FIGURE 11 NORTH AMERICA IS EXPECTED TO DOMINATE THE MARKET FOR TUMOR ABLATION AND ASIA PACIFIC IS EXPECTED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD 2017 TO 2024 FIGURE 12 INCREASING PREVALENCE OF CANCER PATIENTS AND TECHNOLOGICAL ADVANCEMENTS IN ABLATION DEVICES IS EXPECTED TO DRIVE THE MARKET IN THE FORECAST PERIOD 2017 TO 2024 FIGURE 13 TUMOR ABLATION SYSTEMS MARKET SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE TUMOR ABLATION MARKET IN 2017 & 2024 FIGURE 14 ASIA-PACIFIC IS DOMINATING REGION FOR TUMOR ABLATION MANUFACTURERS IN THE FORECAST PERIOD TO 2024 FIGURE 15 GLOBAL TUMOR ABLATION MARKET: BY TYPE, 2016 FIGURE 16 GLOBAL TUMOR ABLATION MARKET: BY CANCER TYPE, 2016 FIGURE 17 DIAGNOSED CASES OF LUNG CANCER IN U.S., 2014 FIGURE 18 DEATH CASES RECORDED DUE TO LUNG CANCER IN U.S., 2014 FIGURE 19 GLOBAL TUMOR ABLATION MARKET: BY MODE OF TREATMENT, 2016 FIGURE 20 GLOBAL TUMOR ABLATION MARKET DOMINATED BY HOSPITALS FIGURE 21 GLOBAL TUMOR ABLATION MARKET SNAPSHOT (2016) FIGURE 22 GLOBAL TUMOR ABLATION MARKET: BY REGION (2016) FIGURE 23 GLOBAL TUMOR ABLATION MARKET : BY REGION (2017) FIGURE 24 GLOBAL TUMOR ABLATION MARKET BY REGION (2017 & 2024) FIGURE 25 GLOBAL TUMOR ABLATION MARKET, BY TYPE (2017 & 2024) FIGURE 26 NORTH AMERICA TUMOR ABLATION MARKET SNAPSHOT (2016) FIGURE 27 NORTH AMERICA TUMOR ABLATION MARKET: BY COUNTRY (2016) FIGURE 28 NORTH AMERICA TUMOR ABLATION MARKET : BY COUNTRY (2017) FIGURE 29 NORTH AMERICA TUMOR ABLATION MARKET BY COUNTRY (2017 & 2024) FIGURE 30 NORTH AMERICA TUMOR ABLATION MARKET, BY TYPE (2017 & 2024) FIGURE 31 EUROPE TUMOR ABLATION MARKET SNAPSHOT (2016) FIGURE 32 EUROPE TUMOR ABLATION MARKET: BY COUNTRY (2016) FIGURE 33 EUROPE TUMOR ABLATION MARKET BY COUNTRY (2017) FIGURE 34 EUROPE TUMOR ABLATION MARKET, BY COUNTRY (2016 & 2024) FIGURE 35 EUROPE TUMOR ABLATION MARKET BY TYPE (2017& 2024) FIGURE 36 ASIA-PACIFIC TUMOR ABLATION MARKET : SNAPSHOT (2016) FIGURE 37 ASIA-PACIFIC TUMOR ABLATION MARKET: BY COUNTRY (2016) FIGURE 38 ASIA-PACIFIC TUMOR ABLATION MARKET : BY COUNTRY (2017) FIGURE 39 ASIA PACIFIC TUMOR ABLATION MARKET, BY COUNTRY (2016 & 2024) FIGURE 40 ASIA-PACIFIC TUMOR ABLATION MARKET :BY TYPE (2017 & 2024) FIGURE 41 SOUTH AMERICA TUMOR ABLATION MARKET : SNAPSHOT (2016) FIGURE 42 SOUTH AMERICA TUMOR ABLATION MARKET: BY COUNTRY (2016) FIGURE 43 SOUTH AMERICA TUMOR ABLATION MARKET : BY COUNTRY (2017) FIGURE 44 SOUTH AMERICA TUMOR ABLATION MARKET, BY COUNTRY (2016 & 2024) FIGURE 45 SOUTH AMERICA TUMOR ABLATION MARKET : BY TYPE (2017 & 2024) FIGURE 46 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET: SNAPSHOT (2016) FIGURE 47 MIDDLE EAST & AFRICA TUMOR ABLATION MARKET: BY COUNTRY (2016) FIGURE 48 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET: BY COUNTRY (2017) FIGURE 49 MIDDLE EAST & AFRICA TUMOR ABLATION MARKET, BY COUNTRY (2016 & 2024) FIGURE 50 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET: BY TYPE (2017 & 2024) FIGURE 51 GLOBAL TUMOR ABLATION MARKET: COMPANY SHARE 2016 (%) FIGURE 52 NORTH AMERICA TUMOR ABLATION MARKET: COMPANY SHARE 2016 (%) FIGURE 53 EUROPE TUMOR ABLATION MARKET: COMPANY SHARE 2016 (%) FIGURE 54 ASIA-PACIFIC TUMOR ABLATION MARKET: COMPANY SHARE 2016 (%)

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART